Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and ...
15h
Barchart on MSNDexCom Stock Outlook: Is Wall Street Bullish or Bearish?San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that focuses on the design, development, and ...
A new bill in Arkansas is the first on a state level to try and stem the “migration” of coverage for continuous glucose monitors to a pharmacy-only benefit.
Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
Smart Rings are an increasingly popular wearables trend, with a number of brands on the market, but how do the popular Oura ...
7h
Hosted on MSNDexcom Stock Makes A Recovery After Its Fourth-Quarter FumbleDexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.
West Pharmaceutical Services Inc (WST) reports steady sales growth and strategic investments amid evolving market conditions ...
12h
Barchart on MSNStocks Shake off Weak Retail Sales Report due to Lower US Bond YieldsStocks were undercut by today’s weaker-than-expected US Jan retail sales report, which fell by -0.9%, weaker than expectations of -0.2%. Excluding autos, Jan retail sales fell by -0.4%, weaker than ...
JAMA today published outcomes from a study evaluating the safety and efficacy of the Insulet Omnipod 5 in adults with type 2 ...
VGM Group’s acquisition of mask-fitting platform SleepGlad rounds out the company’s respiratory offering and better aligns it ...
Johnson & Johnson MedTech recently launched their Cereglide 92 catheter system for the treatment of acute ischemic stroke.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results